Classification
Compound class	Synthetic organic
Approved drug?	Yes (source: FDA (2001), EMA (2002))

IUPAC Name

(2R,3S,4S,5R,6R)-3-{[(2R,3R,4R,5R,6R)-5-{[(2R,3R,4R,5S,6S)-6-carboxy-5-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-3,4-dihydroxyoxan-2-yl]oxy}-3-(sulfoamino)-4-(sulfooxy)-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-4-hydroxy-6-{[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-[(sulfooxy)methyl]oxan-3-yl]oxy}-5-(sulfooxy)oxane-2-carboxylic acid

International Nonproprietary Names
INN number	INN
7653	fondaparinux sodium

Synonyms

Arixtra®

Database Links
CAS Registry No.	114870-03-0
ChEMBL Ligand	CHEMBL1201202
DrugBank Ligand	DB00569
PubChem CID	5282448
RCSB PDB Ligand	NTO
Search Google for chemical match using the InChIKey	KANJSNBRCNMZMV-ABRZTLGGSA-N
Search Google for chemicals with the same backbone	KANJSNBRCNMZMV
Search PubMed clinical trials	fondaparinux sodium
Search PubMed titles	fondaparinux sodium
Search PubMed titles/abstracts	fondaparinux sodium
Wikipedia	Fondaparinux

Comments

Synthetic pentasaccharide Factor Xa inhibitor (via ATIII binding). The ChEMBL and PubChem links given here are without the sodium ions contained in the INN structure of this compound. Database entries include the sodium salt (e.g. PubChem CID 636380).